The results of short-term supplementation studies are primarily responsible for the belief that LC supplementation does not affect metabolism
Table 1: Synergistic Functional Distribution of the KLIKGLOW Protocol Clinical researchers utilizing peptide therapies note that when administered in isolation, a single peptide may successfully upregulate a specific biological pathway, only to have the overall healing process hindered by a secondary biological limitation
So its pretty likely that theres not going to be a real effect on these other modalities, at least in the initial treatment phase. Dasgupta hopes to see GLP-1s used alongside current treatments, like CPAP
They may also have subclinical conditions that could be affected by metabolic changes
Congenital dermal melanocytosis over the lumbosacral area occurs in greater than two-thirds of newborns in some ethnic populations but typically resolves by puberty
doi:10.1097/HJR.0b013e32828622d7 Sasaninia K, Kelley M, Abnousian A, et al
